Recent studies underscore Mylo's superior efficacy, showcasing an impressive 44% reduction in axial length compared to conventional single-vision distance spectacles. This reduction translates to a leading CARE (Cumulative Absolute Reduction in Axial Elongation) value of 0.29, affirming Mylo's effectiveness in slowing myopia progression. With its proven silicone hydrogel material and availability in powers up to -8.00 cylinders, Mylo not only meets diverse vision needs but also effectively addresses astigmatism concerns. Enhanced by swift delivery and optician-led technical support, Mylo stands as a comprehensive choice in the pursuit of highly effective myopia control.
